Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers
Open Access
- 16 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 6 (5) , fcae277
Abstract
Compelling evidence suggests that cognitive decline in Alzheimer’s disease is associated with the accumulation and aggregation of tau protein, with the most toxic aggregates being in the form of oligomers. This underscores the necessity for direct isolation and analysis of brain-derived tau oligomers from patients with Alzheimer’s disease, potentially offering novel perspectives into tau toxicity. Alzheimer’s brain-derived tau oligomers are potent inhibitors of synaptic plasticity; however, the involved mechanism is still not fully understood. We previously reported a significantly reduced incidence of Alzheimer’s disease in ageing humans chronically treated with a Food and Drug Administration–approved calcineurin inhibitor, FK506 (tacrolimus), used as an immunosuppressant after solid organ transplant. Using a combination of electrophysiological and RNA-sequencing techniques, we provide here evidence that FK506 has the potential to block the acute toxic effect of brain-derived tau oligomers on synaptic plasticity, as well as to restore the levels of some key synaptic mRNAs. These results further support FK506 as a promising novel therapeutic strategy for the treatment of Alzheimer’s disease.Keywords
Funding Information
- National Institutes of Health
- National Institute on Aging (R01-AG060718-01A1, R01-AG073133-03)
This publication has 67 references indexed in Scilit:
- Interleukin-1β-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT ActivityJournal of Biological Chemistry, 2008
- Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2007
- Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryActa Neuropathologica, 2006
- 14-3-3ζ Is an Effector of Tau Protein PhosphorylationJournal of Biological Chemistry, 2000
- Net interaction between different forms of short-term synaptic plasticity and slow-IPSPs in the hippocampus and auditory cortex.Journal of Neurophysiology, 1998
- Activity‐dependent properties of synaptic transmission at two classes of connections made by rat neocortical pyramidal axons in vitroThe Journal of Physiology, 1997
- Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcmeurin and phosphatase‐2AFEBS Letters, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Tau Proteins and Neurofibrillary DegenerationBrain Pathology, 1991
- Amyloid plaque core protein in Alzheimer disease and Down syndrome.Proceedings of the National Academy of Sciences, 1985